Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed and Oxaliplatin in Recurrent NSCLC
NCT00612677Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Jun 2007
- Primary completion
- Jan 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in non-small cell lung cancer (NSCLC), sponsored by Moffitt Cancer Center. Started Jun 2007; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00612677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612677.